Header Logo

Connection

ALBERT RAIZNER to Drug Evaluation, Preclinical

Back to Details
This is a "connection" page, showing publications ALBERT RAIZNER has written about Drug Evaluation, Preclinical.
ALBERT RAIZNER
Connection Strength
0.014
Drug Evaluation, Preclinical
  1. Effects of SolCD39, a novel inhibitor of Platelet Aggregation, on Platelet Deposition and Aggregation after PTCA in a Porcine Model. J Thromb Thrombolysis. 2005 Apr; 19(2):115-22.
    View in: PubMed
    Score: 0.014
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.